CIK 0001626971
- Non-accelerated filer
- Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464670809
- Phone
- +1 650-900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market buy 10% owner bought 1,176,470 shares at $8.50 ($9,999,995)
- 4 Open-market buy Director bought 588,235 shares at $8.50 ($4,999,998)
- 4 Open-market buy 10% owner bought 588,235 shares at $8.50 ($4,999,998)
- 4 Open-market buy President and CEO bought 100,000 shares at $8.50 ($850,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 10,000 shares at $10.79 ($107,850)
- 4 Open-market buy 10% owner bought 20,000 shares at $10.95 ($219,000)
- 4 Open-market buy President and CEO bought 25,000 shares at an average $9.88 ($247,084)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 13 · 252 filings